Charting the peptide crossreactome between HIV-1 and the human proteome

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 4, 2011, Pages 1385-1400

  Lucchese, Guglielmo ^a   Stufano, Angela ^a   Calabro, Michele ^a   Kanduc, Darja ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Adjuvant induced immune activation; Crossreactivity induced AIDS; HIV escape from immune surveillance; HIV 1 proteome; HIV derived epitopes; HIV vshuman crossreactome; Human proteome

Indexed keywords

DYSFERLIN; EPITOPE; HEPTAPEPTIDE; OCTAPEPTIDE; POLYPROTEIN; PROTEOME; PEPTIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLADDER CANCER; BRAIN DISEASE; CARDIOVASCULAR DISEASE; CORNEA DISEASE; CROSS REACTION; DIARRHEA; DYSFERLINOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPERTENSION; IMMUNOGENICITY; IMMUNOSURVEILLANCE; KIDNEY DISEASE; LIPODYSTROPHY; LYMPHOMA; MUSCLE DISEASE; MYOPATHY; NEUROLOGIC DISEASE; NONHUMAN; SCHIZOPHRENIA; METABOLISM;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CROSS REACTIONS; HIV-1; HUMANS; PEPTIDES; PROTEOME;

EID: 79960346115     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (181)

1. MR Lee, DD Ho, ME Gurney: Functional interaction and partial homology between human immunodeficiency virus and neuroleukin. Science 237, 1047-1051 (1987) (Pubitemid 17131205)
2. A Douvas, S Sobelmen: Multiple overlapping homologies between two rheumatoid antigens and immunosuppressive viruses. Proc Natl Acad Sci USA 88, 6328-6332 (1991) (Pubitemid 21914939)
3. A Douvas, Y Takehana: Cross-reactivity between autoimmune anti-U1 snRNP antibodies and neutralizing epitopes of HIV-1 gp120/41. AIDS Res Hum Retroviruses 10, 253-262 (1994) (Pubitemid 24116781)
4. EW Taylor, A Bhat, RG Nadimpalli, W Zhang, J Kececioglu: HIV-1 encodes a sequence overlapping env gp41 with highly significant similarity to seleniumdependent glutathione peroxidases. J Acquir Immune Defic Syndr Hum Retrovirol 15, 393-394 (1997)
5. G Su, W Min, EW Taylor: An HIV-1 encoded peptide mimics the DNA binding loop of NF-kappaB and binds thioredoxin with high affinity. Mutat Res 579, 133-148 (2005) (Pubitemid 41540138)
6. RL Bjork Jr: HIV-1: seven facets of functional molecular mimicry. Immunol Lett 28, 91-95 (1991)
7. J Habeshaw, E Hounsell, A Dalgleish: Does the HIV envelope induce a chronic graftversus-host-like disease? Immunol Today 13, 207-210 (1992)
8. C Susal, M Kropelin, V Daniel, G Opelz: Molecular mimicry between HIV-1 and antigen receptor molecules: a clue to the pathogenesis of AIDS. Vox Sang 65:10-17 (1993) (Pubitemid 23212381)
9. JF Zagury, H Cantalloube, A Achour, YY Cho, L Fall, A Lachgar, V Chams, A Astgen, D Biou, O Picard, I Callebaut, JP Morton, A Burny, M Feldman, J Bernard, B Bizzini, D Zagury: Striking similarities between HIV-1 Env protein and the apoptosis mediating cell surface antigen Fas. Role in the pathogenesis of AIDS. Biomed Pharmacother 47, 331-335 (1993) (Pubitemid 24003546)
10. HM Cantalloube, CE Nahum, JF Zagury: Screening of protein sequences databanks by Automat for search of host sequences integration and/or autoimmune disorders induction by retroviruses. Biomed Pharmacother 48, 17-26 (1994) (Pubitemid 124009764)
11. RS Root-Bernstein: Antigenic complementarity among AIDS-associated infectious agents and molecular mimicry of lymphocyte proteins as inducers of lymphocytotoxic antibodies and circulating immune complexes. J Clin Virol 31, S16-25 (2004) (Pubitemid 39582778)
12. T Spehar, M Strand: Molecular mimicry between HIV-1 gp41 and an astrocyte isoform of alpha-actinin. J Neurovirol 1, 381-390 (1995)
13. PM Murphy: Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2, 116-122 (2001) (Pubitemid 33707928)
14. F Chen, SL Day, RA Metcalfe, G Sethi, MS Kapembwa, MG Brook, D Churchill, A De Ruiter, S Robinson, CJ Lacey, AP Weetman: Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore) 84, 98-106 (2005) (Pubitemid 40418638)
15. Z Li, MA Nardi, S Karpatkin: Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood 106, 572-576 (2005) (Pubitemid 40981253)
16. GH Tishkoff, LT Hunt: Unexpected molecular mimicry among peptides MHC class II, blood-clotting factor X, and HIV-1 envelope glycoprotein GP120. Thromb Res 98, 343-346 (2000) (Pubitemid 30255938)
17. N Veljkovic: Molecular mimicry of HIV gp120: Possible implications on prevention and therapy of AIDS. Arch Oncol 13, 126-130 (2005)
18. BF Haynes, J Fleming, EW St. Clair, H Katinger G Stiegler, R Kunert, J Robinson, RM Scearce, K Plonk, HF Staats, TL Ortel, H-X Liao, SM Alam: Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308, 1906-1908 (2005) (Pubitemid 40941873)
19. C Natale, T Giannini, A Lucchese, D Kanduc: Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences. Immunol Cell Biol 78, 580-585 (2000)
20. D Kanduc, A Stufano, G Lucchese, A Kusalik: Massive peptide sharing between viral and human proteomes. Peptides 29, 1755-1766 (2008)
21. G Capone, G Novello, C Fasano, B Trost, M Bickis, A Kusalik, D Kanduc. The oligodeoxynucleotide sequences corresponding to never-expressed peptide motifs are mainly located in the non-coding strand. BMC Bioinformatics 11, 383 (2010)
22. NA Jones, X Wei, DR Flower, M Wong, F Michor, MS Saag, BH Hahn, MA Nowak, GM Shaw, P Borrow: Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med 200, 1243-1256 (2004) (Pubitemid 39552566)
23. U Malhotra, J Nolin, JI Mullins, MJ McElrath: Comprehensive epitope analysis of cross-clade Gagspecific T-cell responses in individuals with early HIV-1 infection in the US epidemic. Vaccine 25, 381-390 (2007) (Pubitemid 44856070)
24. X Gong, X Gui, Y Zhang, P Tien: Screening for CD8 cytotoxic T lymphocytes specific for Gag of human immunodeficiency virus type 1 subtype B' Henan isolate from China and identification of novel epitopes restricted by the HLA-A2 and HLAA11 alleles. J Gen Virol 87, 151-158 (2006) (Pubitemid 43056953)
25. DE Kaufmann, PM Bailey, J Sidney, B Wagner, PJ Norris, MN Johnston, LA Cosimi, MM Addo, M Lichterfeld, M Altfeld, N Frahm, C Brander, A Sette, BD Walker, ES Rosenberg: Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol 78, 4463-4477 (2004) (Pubitemid 38501066)
26. WB Dyer, JJ Zaunders, FF Yuan, B Wang, JC Learmont, AF Geczy, NK Saksena, DA McPhee, PR Gorry, JS Sullivan: Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection. Retrovirology 5, 112 (2008)
27. S Zhai, Y Zhuang, Y Song, S Li, D Huang, W Kang, X Li, Q Liao, Y Liu, Z Zhao, Y Lu, Y Sun: HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China. Curr HIV Res 6, 335-350 (2008)
28. L Musey, Y Ding, J Cao, J Lee, C Galloway, A Yuen, KR Jerome, MJ McElrath: Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8+ cytotoxic T lymphocytes. J Virol 77, 291-300 (2003) (Pubitemid 36004969)
29. N Frahm, S Adams, P Kiepiela, CH Linde, HS Hewitt, M Lichterfeld, K Sango, NV Brown, E Pae, AGWurcel, M Altfeld, ME Feeney, TM Allen, T Roach, MA St. John, ES Daar, E Rosenberg, B Korber, F Marincola, BD Walker, PJR Goulder, C Brander: HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J Virol 79, 10218-10225 (2005) (Pubitemid 41098563)
30. M Daucher, DA Price, JM Brenchley, L Lamoreaux, JA Metcalf, C Rehm, E Nies-Kraske, E Urban, C Yoder, D Rock, J Gumkowski, MR Betts, MR Dybul, DC Douek: Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virusspecific CD8+ T cells. J Virol 82, 4102-4114 (2008) (Pubitemid 351521245)
31. PC Matthews, A Prendergast, A Leslie, H Crawford, R Payne, C Rousseau, M Rolland, I Honeyborne, J Carlson, C Kadie, C Brander, K Bishop, N Mlotshwa, JI Mullins, H Coovadia, T Ndung'u, BD Walker, D Heckerman, PJR Goulder: Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol 82, 8548-8559 (2008)
32. DA Dilernia, L Jones, S Rodriguez, G Turk, AE Rubio, S Pampuro, M Gomez-Carrillo, C Bautista, G Deluchi, J Benetucci, MB Lasala, L Lourtau, MH Losso, H Perez, P Cahn, H Salomón: HLA-driven convergence of HIV-1 viral subtypes B and F toward the adaptation to immune responses in human populations. PLoS ONE 3, e3429 (2008)
33. A Milicic, CTT Edwards, S Hué, J Fox, H Brown, T Pillay, JW Drijfhout, JN Weber, EC Holmes, SJ Fidler, HT Zhang, RE Phillips: Sexual transmission of single human immunodeficiency virus type 1 virions encoding highly polymorphic multisite cytotoxic T-lymphocyte escape variants. J Virol 79, 13953-13962 (2005) (Pubitemid 41552694)
34. A Achour, O Picard, D Zagury, P Sarin, R Gallo, P Naylor, A Goldstein: Hgp-30, a synthetic analogue of human immunodeficiency virus p17, is a target for cytotoxic lymphocytes in hiv-infected individuals. Proc Natl Acad Sci USA 87, 7045-7049 (1990)
35. B Wahren, J Rosen, E Sandstrom, T Mathiesen, S Modrow, H Wigzell: Hiv-1 peptides induce a proliferative response in lymphocytes from infected persons. J Acquir Immune Defic Syndr 4, 448-456 (1989) (Pubitemid 19233870)
36. TM Allen, M Altfeld, SC Geer, ET Kalife, C Moore, KM O'Sullivan, I De Souza, ME Feeney, RL Eldridge, EL Maier, DE Kaufmann, MP Lahaie, L Reyor, G Tanzi, MN Johnston, C Brander, R Draenert, JK Rockstroh, H Jessen, ES Rosenberg, SA Mallal, BD Walker: Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 79, 13239-13249 (2005) (Pubitemid 41508139)
37. N Frahm, BT Korber, CM Adams, JJ Szinger, R Draenert, MM Addo, ME Feeney, K Yusim, K Sango, NV Brown, D Sen Gupta, A Piechocka-Trocha, T Simonis, FM Marincola, AG Wurcel, DR Stone, CJ Russell, P Adolf, D Cohen, T Roach, A St John, A Khatri, K Davis, J Mullins, PJR Goulder, BD Walker, C Brander: Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol 78, 2187-2200 (2004) (Pubitemid 38228912)
38. L Dorrell, BE Willcox, EY Jones, G Gillespie, H Njai, S Sabally, A Jaye, K De Gleria, T Rostron, E Lepin, A McMichael, H Whittle, S Rowland-Jones: Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and crossreactive peptides in human immunodeficiency virus type-1 gag through HLA-b53. Eur J Immunol 31, 1747-1756 (2001) (Pubitemid 32547337)
39. A Buchacher, R Predl, K Strutzenberger, W Steinfellner, A Trkola, M Purtscher, G Gruber, C Tauer, F Steindl, A Jungbauer, H Katinger: Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res Hum Retroviruses 10, 359-369 (1994) (Pubitemid 24141210)
40. L Gudmundsdotter, D Bernasconi, B Hejdeman, E Sandstrom, A Alaeus, K Lidman, B Ensoli, B Wahren, S Buttò: Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles. Vaccine 26, 5182-5187 (2008)
41. P Kiepiela, AJ Leslie, I Honeyborne, D Ramduth, C Thobakgale, S Chetty, P Rathnavalu, C Moore, KJ Pfafferott, L Hilton, P Zimbwa, S Moore, T Allen, C Brander, MM Addo, M Altfeld, I James, S Mallal, M Bunce, LD Barber, J Szinger, C Day, P Klenerman, J Mullins, B Korber, HM Coovadia, BD Walker, PJR Goulder: Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432, 769-775 (2004)
42. P Kiepiela, K Ngumbela, C Thobakgale, D Ramduth, I Honeyborne, E Moodley, S Reddy, C De Pierres, Z Mncube, N Mkhwanazi, K Bishop, M Van der Stok, K Nair, N Khan, H Crawford, R Payne, A Leslie, J Prado, A Prendergast, J Frater, N McCarthy, C Brander, GH Learn, D Nickle, C Rousseau, H Coovadia, JI Mullins, D Heckerman, BD Walker, P Goulder: CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13, 46-53 (2007) (Pubitemid 46067385)
43. N Frahm, P. Kiepiela, S. Adams, C. H. Linde, H. S. Hewitt, K. Sango, M. E. Feeney, M. M. Addo, M. Lichterfeld, M. P Lahaie, E Pae, AG Wurcel, T Roach, MA St John, M Altfeld, FM Marincola, C Moore, S Mallal, M Carrington, D Heckerman, TM Allen, JI Mullins, B T Korber, PJR Goulder, BD Walker, C Brander: Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol 7, 173-178 (2006) (Pubitemid 43135883)
44. DR Chopera, Z Woodman, K Mlisana, M Mlotshwa, DP Martin, C Seoighe, F Treurnicht, DA De Rosa, W Hide, SA Karim, CM Gray, C Williamson, CAPRISA 002 Study Team: Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PloS Pathog 4:e1000033 (2008)
45. V Novitsky, N Rybak, MF McLane, P Gilbert, P Chigwedere, I Klein, S Gaolekwe, SY Chang, T Peter, I Thior, T Ndung'u, F Vannberg, BT Foley, R Marlink, TH Lee, M Essex: Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J Virol 75, 9210-9228 (2001) (Pubitemid 32851925)
46. N Goonetilleke, S Moore, L Dally, N Winstone, I Cebere, A Mahmoud, S Pinheiro, G Gillespie, D Brown, V Loach, J Roberts, A Guimaraes-Walker, P Hayes, K Loughran, C Smith, J De Bont, C Verlinde, D Vooijs, C Schmidt, M Boaz, J Gilmour, P Fast, L Dorrell, T Hanke, AJ McMichael: Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA-and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ Tcell epitopes. J Virol 80, 4717-4728 (2006)
47. XG Yu, H Shang, MM. Addo, RL Eldridge, MN Phillips, ME Feeney, D Strick, C Brander, PJR Goulder, ES Rosenberg, BD Walker, M Altfeld: Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses. AIDS 16, 321-328 (2002) (Pubitemid 34165362)
48. S Wang, Y Sun, S Zhai, Y Zhuang, S Zhao, W Kang, X Li, D Huang, XG Yu, BD Walker, MA Altfeld: Identification of HLA-A11-restricted HIV-1-specific cytotoxic T-lymphocyte epitopes in China. Curr HIV Res 5, 119-128 (2007) (Pubitemid 46062365)
49. M Aidoo, S Sawadogo, EC Bile, C Yang, JN Nkengasong, JM McNicholl: Viral, HLA and T cell elements in cross-reactive immune responses to HIV-1 subtype A, CRF01-AE and CRF02-AG vaccine sequence in Ivorian blood donors. Vaccine 26, 4830-4839 (2008)
50. S McAdam, P Kaleebu, P Krausa, P Goulder, N French, B Collin, T Blanchard, J Whitworth, A McMichael, F Gotch: Cross-clade recognition of p55 by cytotoxic t lymphocytes in HIV-1 infection. AIDS 12, 571-579 (1998) (Pubitemid 28162095)
51. S Venturini, DE Mosier, DR Burton, P Poignard: Characterization of human immunodeficiency virus type 1 (HIV-1) Gag-and Gag peptide-specific CD4+ T-cell clones from an HIV-1-seronegative donor following in vitro immunization. J Virol 76, 6987-6999 (2002) (Pubitemid 41246213)
52. L Musey, Y Hu, L Eckert, M Christensen, T Karchmer, MJ McElrath: HIV-1 induces cytotoxic t lymphocytes in the cervix of infected women. J Exp Med 185, 293-303 (1997) (Pubitemid 27078286)
53. E Boritz, EL Rapaport, TB Campbell, JR Koeppe, CC Wilson: CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease. Virology 361, 34-44 (2007) (Pubitemid 46551217)
54. MR Thakar, LS Bhonge, SK Lakhashe, U Shankarkumar, SS Sane, SS Kulkarni, BA Mahajan, RS Paranjape: Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef. J Infect Dis 192, 749-759 (2005) (Pubitemid 41193072)
55. PJ Goulder, C Brander, K Annamalai, N Mngqundaniso, U Govender, Y Tang, S He, KE Hartman, CA O'Callaghan, GS Ogg, MA Altfeld, ES Rosenberg, H Cao, SA Kalams, M Hammond, M Bunce, SI Pelton, SA Burchett, K McIntosh, HM Coovadia, BD Walker: Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol 74, 5679-5690 (2000) (Pubitemid 30346603)
56. J Lieberman, JA Fabry, DM Fong, GR Parkerson 3rd: Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual. AIDS Res Hum Retroviruses 13, 383-392 (1997) (Pubitemid 27144349)
57. MM Addo, XG Yu, A Rathod, D Cohen, RL Eldridge, D Strick, MN Johnston, C Corcoran, AG Wurcel, CA Fitzpatrick, ME Feeney, WR Rodriguez, N Basgoz, R Draenert, DR Stone, C Brander, PJR Goulder, ES Rosenberg, M Altfeld, BD Walker: Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77, 2081-2092 (2003) (Pubitemid 36110021)
58. S Zhao, S Zhai, Y Zhuang, S Wang, D Huang, W Kang, X Li, XG Yu, BD Walker, MA Altfeld, Y Sun: Inter-clade cross-reactivity of HIV-1-specific T cell responses in human immunodeficiency virus type 1 infection in China. Curr HIV Res 5, 251-259 (2007) (Pubitemid 46488200)
59. *57+ elite suppressors despite CTL escape mutations. J Exp Med 203, 1357-1369 (2006) (Pubitemid 43736603)
60. JR Bailey, K O'Connell, HC Yang Y Han, J Xu, B Jilek, TM Williams, SC Ray, RF Siliciano, JN Blankson: Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. J Virol 82, 7395-7410 (2008) (Pubitemid 352031208)
61. JM Claverie, P Kourilsky, P Langlade-Demoyen, A Chalufour-Prochnicka, G Dadaglio, F Tekaia, F Plata, K Bougueleret: T-immunogenic peptides are constituted of rare sequence patterns.use in the identification of t epitopes in the human immunodeficiency virus gag protein. Eur J Immunol 18, 1547-1553 (1988) (Pubitemid 18269338)
62. AZ Maksyutov, AG Bachinskii, SI Bazhan: Searching for local similarities between HIV-1 and human proteins.application to vaccines. Mol Biol (Mosk) 36, 346-358 (2002)
63. AS De Groot, DS Rivera, JA McMurry, S Buus, W Martin: Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV. Vaccine 26, 3059-3071 (2008)
64. MJ Geels, SA Dubey, KAnderson, E Baan, M Bakker, G Pollakis, WA Paxton, JW Shiver, J Goudsmit: Broad cross-clade T-cell responses to Gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): Importance of HLA anchor residue conservation. J Virol 79, 11247-11258 (2005) (Pubitemid 41170667)
65. M Altfeld, TM Allen, XG Yu, MN Johnston, D Agrawal, BT Korber, DC Montefiori, DH O'Connor, BT Davis, P K Lee, EL Maier, JHarlow, PJR Goulder, C Brander, ES Rosenberg, BD Walker: HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 420, 434-439 (2002) (Pubitemid 35415656)
66. CC Wilson, MJ Newman, BD Livingston, S MaWhinney, JE Forster, J Scott, RT Schooley, CA Benson: Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy. Clin Vaccine Immunol 15, 986-994 (2008) (Pubitemid 351967010)
67. SG Fonseca, A Coutinho-Silva, LAM Fonseca, AC Segurado, SL Moraes, H Rodrigues, J Hammer, EG Kallás, J Sidney, A Sette, J Kalil, E Cunha-Neto: Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients. AIDS 20, 2263-2273 (2006) (Pubitemid 44789528)
68. FA Castelli, D Houitte, G Munier, N Szely, A Lecoq, JP Briand, S Muller, B Maillere: Immunoprevalence of the CD4+ T-cell response to HIV Tat and Vpr proteins is provided by clustered and disperse epitopes, respectively. Eur J Immunol 38, 2821-2831 (2008)
69. DM Noonan, A Gringeri, R Meazza, O Rosso, S Mazza, M Muca-Perja, H Le Buanec, RS Accolla, A Albini, S Ferrini: Identification of immunodominant epitopes in inactivated Tat-vaccinated healthy and HIV-1-infected volunteers. J Acquir Immune Defic Syndr 33, 47-55 (2003) (Pubitemid 36547241)
70. V Ovod, A Lagerstedt, A Ranki, FO Gombert, R Spohn, M Tahtinen, G Jung, KJ Krohn: Immunological variation and immunohistochemical localization of HIV-1 nef demonstrated with monoclonal antibodies. AIDS 6, 25-34 (1992)
71. IMM Schellens, C Kesmir, F Miedema, D Van Baarle, JA M. Borghans: An unanticipated lack of consensus cytotoxic T lymphocyte epitopes in HIV-1 databases: The contribution of prediction programs. AIDS 22, 33-37 (2008) (Pubitemid 350294875)
72. A Ranki, M Nyberg, V Ovod, M Haltia, I Elovaara, R Raininko, H Haapasalo, K Krohn: Abundant expression of HIV nef and rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9, 1001-1008 (1995)
73. GJ Gorse, LR Baden, M Wecker, MJ Newman, G Ferrari, KJ Weinhold, BD Livingston, TL Villafana, H Li, E Noonan, ND Russell, HIV Vaccine Trials Network: Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1) - uninfected adults. Vaccine 26, 215-223 (2008) (Pubitemid 350278539)
74. C Guillon, K Stankovic, Y Ataman-Önal, F Biron, B Verrier: Evidence for CTL-mediated selection of Tat and Rev mutants after the onset of the asymptomatic period during HIV type 1 infection. AIDS Res Hum Retroviruses 22, 1283-1292 (2006) (Pubitemid 46095247)
75. MM Addo, XG Yu, ES Rosenberg, BD Walker, M Altfeld: Cytotoxic T-lymphocyte (CTL) responses directed against regulatory and accessory proteins in HIV-1 infection. DNA Cell Biol 21, 671-678 (2002)
76. S Corbet, HV Nielsen, L Vinner, S Lauemoller, D Therrien, S Tang, G Kronborg, L Mathiesen, P Chaplin, S Brunak, S Buus, A Fomsgaard: Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes. J Gen Virol 84, 2409-2421 (2003) (Pubitemid 37063130)
77. M Thorn, S Tang, D Therrien, H Kløverpris, L Vinner, G Kronborg, J Gerstoft, S Corbet, A Fomsgaard: Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals. APMIS 115, 757-768 (2007) (Pubitemid 46854985)
78. A Fomsgaard, L Vinner, D Therrien, LB Jørgensen, C Nielsen, L Mathiesen, C Pedersen, S Corbet: Full-length characterization of A1/D intersubtype recombinant genomesfrom a therapyinduced HIV type 1 controller during acute infection and his noncontrolling partner. AIDS Res Hum Retroviruses 24, 463-472 (2008) (Pubitemid 351457736)
79. RP Johnson, SA Hammond, A Trocha, RF Siliciano, BD Walker: Epitope specificity of mhc restricted cytotoxic t lymphocytes induced by candidate HIV-1 vaccine. AIDS Res Hum Retroviruses 10, S73-75 (1994) (Pubitemid 24375441)
80. G Dadaglio, A Leroux, P Langlade-Demoyen, EM Bahraoui, F Traincard, R Fisher, F Plata: Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes. J Immunol 147, 2302-2309 (1991)
81. ATL De Queiroz, LA Santos, DR Moreau, T De Oliveira, DI Watkins, B Galvão-Castro, LCJ Alcantara: Identification and characterization of previously described epitopes in HIV-1 subtypes B, C, F and BF in Brazil. Braz J Infect Dis 11, 27-30 (2007) (Pubitemid 47024091)
82. A Llano, N Frahm, C Brander, 2009. How to optimally define optimal cytotoxic T lymphocyte epitopes in HIV infection? In: HIV Molecular Immunology. (B Korber, C Brander, BF Haynes, R Koup, JP Moore, BD Walker, DI. Watkins, eds), Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, New Mexico, p. 3 (2009)
83. Z Moukrim, A Achour: Cytotoxic T lymphocytes specific for the synthetic VEINCTR peptide, a sequence found within the Fas molecule and env gp120 in the blood of HIV-1 seropositive individuals. Cell Mol Biol (Noisy-legrand) 41, 439-44 (1995)
84. KV Sitz, S Ratto-Kim, AS Hodgkins, ML Robb, DL Birx: Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infectedindividuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls. J Infect Dis 179, 817-824 (1999) (Pubitemid 29159326)
85. AM Geretti, CA Van Baalen, JC Borleffs, CA Van Els, AD Osterhaus: Kinetics and specificities of the T helper-cell response to gp120 in the asymptomatic stage of HIV-1 infection. Scand J Immunol 39, 355-362 (1994) (Pubitemid 24199542)
86. P Shankar, JA Fabry, DM Fong, J Lieberman: Three regions of HIV-1 gp160 contain clusters of immunodominant ctl epitopes. Immunol Lett 52, 23-30 (1996) (Pubitemid 26279100)
87. D Mirano-Bascos, M Tary-Lehmann, SJ Landry: Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120. Eur J Immunol 38, 1231-1237 (2008)
88. AS De Groot, EA Bishop, B Khan, M Lally, L Marcon, J Franco, KH Mayer, CCJ Carpenter, W Martin: Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. Methods 34, 476-487 (2004) (Pubitemid 39469055)
89. RD Schrier, JW Gnann, R Landes, C Lockshin, D Richman, A McCutchan, C Kennedy, MBA Oldstone, JA Nelson: T-cell recognition of HIV synthetic peptides in a natural infection. J Immunol 142, 1166-1176 (1989) (Pubitemid 19067487)
90. PN Nehete, SJ Schapiro, PC Johnson, KK Murthy, WC Satterfield, KJ Sastry: A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans. Viral Immunol 11, 147-158 (1998) (Pubitemid 29068944)
91. H Horton, C Havenar-Daughton, D Lee, E Moore, J Cao, J McNevin, T Andrus, H Zhu, A Rubin, T Zhu, C Celum, MJ McElrath: Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection. J Virol 80, 9779-9788 (2006) (Pubitemid 44435652)
92. J Lieberman, JA Fabry, MC Kuo, P Earl, B Moss, PR Skolnik: Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in gp160 and reverse transcriptase. J Immunol 148, 2738-2747 (1992)
93. J Lieberman, JA Fabry, P Shankar, L Beckett, PR Skolnik: Ex vivo expansion of HIV type 1-specific cytolyticT cells from HIV type 1-seropositive subjects. AIDS ResHum Retroviruses 11, 257-271 (1995)
94. K Smits, V Iannucci, V Stove, P Van Hauwe, E Naessens, PJ Meuwissen, KK Ariën, M Bentahir, J Plum, B Verhasselt: Rho GTPase Cdc42 is essential for human T-cell development. Haematologica 95, 367-375 (2010)
95. T Copetti, C Bertoli, E Dalla, F Demarchi, C Schneider: p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol 29, 2594-2608 (2009)
96. P Dai, SY Jeong, Y Yu, T Leng, W Wu, Xie L, X Chen: Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins. J Immunol 182, 3450-3460 (2009)
97. FS Rosen, IUIS Scientific Committee: Primary immunodeficiency diseases report of an IUIS Scientific Committee. Clin Exp Immunol 118, S1-S28 (1999)
98. M De Hert, M Wampers, D Van Eyck, J Peuskens, T Franic, D Vidovic, K Van Herck, P Van Damme: Prevalence of HIV and hepatitis C infection among patients with schizophrenia. Schizophr Res 108, 307-308 (2009)
99. F Castets, M Bartoli, JV Barnier, G Baillat, P Salin, A Moqrich, JP Bourgeois, F Denizot, G Rougon, G Calothy, A Monneron: A novel calmodulin-binding protein, belonging to the WD-repeat family, is localized in dendrites of a subset of CNS neurons. J Cell Biol 134, 1051-1062 (1996) (Pubitemid 26278227)
100. D Martins-de-Souza, WF Gattaz, A Schmitt, C Rewerts, G Maccarrone, E Dias-Neto, CW Turck: Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci 259, 151-163 (2009)
101. Q Lu, DC Pallas, HK Surks, WE Baur, ME Mendelsohn, RH Karas: Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. Proc Natl Acad Sci USA 101, 17126-17131 (2004) (Pubitemid 39627785)
102. EC Seaberg, L Benning, AR Sharrett, JM Lazar, HN Hodis, WJ Mack, MJ Siedner, JP Phair, LA Kingsley, RC Kaplan: Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke 41, 2163-2170 (2010)
103. KK Singh, X Ge, Y Mao, L Drane, K Meletis, BA Samuels, LH Tsai: Dixdc1 is a critical regulator of DISC1 and embryonic cortical development. Neuron 67, 33-48 (2010)
104. X Ding, Y Jin, Y Wu, Y Wu, H Wu, L Xiong, X Song, S Liu, W Fan, M Fan: Localization and cellular distribution of CPNE5 in embryonic mouse brain. Brain Res 1224, 20-28 (2008)
105. N Baillieu, J Potterton: The extent of delay of language, motor, and cognitive development in HIV-positive infants. J Neurol Phys Ther 32, 118-121 (2008)
106. S Sánchez-Ramón, C Cantó-Nogués, A Muñoz-Fernández: Reconstructing the course of HIV-1-associated progressive encephalopathy in children. Med Sci Monit 8, RA249-252 (2002)
107. J Majercak, WJ Ray, A Espeseth, A Simon, XP Shi, C Wolffe, K Getty, S Marine, E Stec, M Ferrer, B Strulovici, S Bartz, A Gates, M Xu, Q Huang, L Ma, P Shughrue, J Burchard, D Colussi, B Pietrak, J Kahana, D Beher, T Rosahl, M Shearman, D Hazuda, AB Sachs, KS Koblan, GR Seabrook, DJ Stone: LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 103, 17967-17972 (2006) (Pubitemid 44852269)
108. M Gisslén, J Krut, U Andreasson, K Blennow, P Cinque, BJ Brew, S Spudich, L Hagberg, L Rosengren, RW Price, H Zetterberg: Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol 9, 63 (2009)
109. M Pantelidou, SE Zographos, CW Lederer, T Kyriakides, MW Pfaffl, N Santama: Differential expression of molecular motors in the motor cortex of sporadic ALS. Neurobiol Dis 26, 577-589 (2007) (Pubitemid 46756325)
110. YJ Kim, Y Fan, P Laurie, JM Kim, J Ravits: No evidence of HIV pol gene in spinal cord tissues in sporadic ALS by real-time RT-PCR. Amyotroph Lateral Scler 11, 91-96 (2010)
111. AL McCormick, RH Jr. Brown, ME Cudkowicz, A Al-Chalabi, JA Garson: Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology 70, 278-283 (2008) (Pubitemid 351156807)
112. DJ MacGowan, SN Scelsa, TE Imperato, KN Liu, P Baron, B Polsky: A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology 68, 1944-1946 (2007) (Pubitemid 46848628)
113. C Zona, M Pieri, I Carunchio: Voltage-dependent sodium channels in spinal cord motor neurons display rapid recovery from fast inactivation in a mouse model of amyotrophic lateral sclerosis. J Neurophysiol 96, 3314-3322 (2006) (Pubitemid 44837875)
114. S Hadano, CK Hand, H Osuga, Y Yanagisawa, A Otomo, RS Devon, N Miyamoto, J Showguchi-Miyata, Y Okada, R Singaraja, DA Figlewicz, T Kwiatkowski, BA Hosler, T Sagie, J Skaug, J Nasir, RH Brown Jr, SW Scherer, GA Rouleau, MR Hayden, JE Ikeda: A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 29, 166-173 (2001) (Pubitemid 32952653)
115. LQ Le, LF Parada: Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene 26, 4609-4616 (2007) (Pubitemid 47067408)
116. MV Johnston, A Ishida, WN Ishida, HB Matsushita, A Nishimura, M Tsuji: Plasticity and injury in the developing brain. Brain Dev 31, 1-10 (2009)
117. R Shirakawa, S Fukai, M Kawato, T Higashi, H Kondo, T Ikeda, E Nakayama, K Okawa, O Nureki, T Kimura, T Kita, H Horiuchi: Tuberous sclerosis tumor suppressor complex-like complexes act as GTPaseactivating proteins for Ral GTPases. J Biol Chem 284, 21580-21588 (2009)
118. JM Tee, MP Peppelenbosch: Anchoring skeletal muscle development and disease: the role of ankyrin repeat domain containing proteins in muscle physiology. Crit Rev Biochem Mol Biol 45, 318-330 (2010)
119. P Chariot, R Gherardi: Myopathy and HIV infection. Curr Opin Rheumatol 7, 497-502 (1995)
120. Y Huang, SH Laval, A Van Remoortere, J Baudier, C Benaud, LV Anderson, V Straub, A Deelder, RR Frants, JT Den Dunnen, K Bushby, SM Van der Maarel: AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J 21, 732-742 (2007) (Pubitemid 46348249)
121. C Abramovich, EA Chavez, PM Lansdorp, RK Humphries: Functional characterization of multiple domains involved in the subcellular localization of the hematopoietic Pbx interacting protein (HPIP). Oncogene 21, 6766-6771 (2002) (Pubitemid 35221918)
122. EM Gaughan, BJ Dezube, M Bower, DM Aboulafia, G Bohac, TP Cooley, L Pantanowitz: HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management. BMC Urol 9, 10 (2009)
123. B Chatton, Bocco JL, Gaire M, Hauss C, Reimund B, Goetz J, Kedinger C: Transcriptional activation by the adenovirus larger E1a product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1a. Mol Cell Biol 13, 561-570 (1993) (Pubitemid 23006933)
124. T Maekawa, S Kim, D Nakai, C Makino, T Takagi, H Ogura, K Yamada, B Chatton, S Ishii: Social isolation stress induces ATF-7 phosphorylation and impairs silencing of the 5-HT 5B receptor gene. EMBO J 29, 196-208 (2010)
125. M Santos, S Ruiz, MF Lara, C Segrelles, M Moral, AB Martínez-Cruz, C Ballestín, C Lorz, R García-Escudero, JM Paramio: Susceptibility of pRb-deficient epidermis to chemical skin carcinogenesis is dependent on the p107 allele dosage. Mol Carcinog 47, 815-821 (2008)
126. DL Burkhart, SE Wirt, AF Zmoos, MS Kareta, J Sage: Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions. PLoS Genet 6, e1001003 (2010)
127. KJ Smith, HG Skelton: Peroxisomal proliferatoractivated ligand therapy for HIV lipodystrophy. Clin Exp Dermatol 26, 155-161 (2001) (Pubitemid 32275707)
128. RO Scott, WR Thelin, SL Milgram: A novel PDZ protein regulates the activity of guanylyl cyclase C, the heatstable enterotoxin receptor. J Biol Chem 277, 22934-22941 (2002) (Pubitemid 34967277)
129. ER Fernandes, C Pagliari, FF Tuon, HF De Andrade Jr, M Averbach, MI Duarte: Chronic colitis associated with HIV infection can be related to intraepithelial infiltration of the colon by CD8+ T lymphocytes. Int J STD AIDS 19, 524-528 (2008)
130. A Schmidt, SJ Rutledge, N Endo, EE Opas, H Tanaka, G Wesolowski, CT Leu, Z Huang, C Ramachandaran, SB Rodan, GA Rodan: Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. Proc Natl Acad Sci USA 93, 3068-3073 (1996) (Pubitemid 26114364)
131. A Bonjoch, M Figueras, C Estany, N Perez-Alvarez, J Rosales, L Del Rio, S Di Gregorio, J Puig, G Gómez, B Clotet, E Negredo; the Osteoporosis Study Group: High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 24, 2827-2833 (2010)
132. S Arora, M Agrawal, L Sun, F Duffoo, M Zaidi, J Iqbal: HIV and Bone Loss. Curr Osteoporos Rep 8, 219-226 (2010)
133. P Ellies, G Renard, S Valleix, PY Boelle, P Dighiero: Clinical outcome of eight BIGH3-linked corneal dystrophies. Ophthalmology 109, 793-797 (2002) (Pubitemid 34270141)
134. S Gharai, P Venkatesh, R Tandon, S Garg: Peripheral ulcerative keratitis and central retinal vein occlusion as the initial manifestation of HIV infection. Ocul Immunol Inflamm 15, 407-409 (2007) (Pubitemid 350035483)
135. JE Thorne, KH Shah, DM Brown, GN Holland, DA Jabs: Posterior intracorneal opacities in patients with HIV infection. Ocul Immunol Inflamm 13, 25-31 (2005) (Pubitemid 41702781)
136. NR Acharya, ET Cunningham Jr: Corneal, anterior segment, and adnexal manifestations of human immunodeficiency virus. Int Ophthalmol Clin 38, 161-177 (1998) (Pubitemid 29009194)
137. MM Estrella, DM Fine: Screening for chronic kidney disease in HIV-infected patients. Adv Chronic Kidney Dis 17, 26-35 (2010)
138. AK Singh, H Amlal, PJ Haas, U Dringenberg, S Fussell, SL Barone, R Engelhardt, J Zuo, U Seidler, M Soleimani: Fructose-induced hypertension: essential role of chloride and fructose absorbing transporters PAT1 and Glut5. Kidney Int 74, 438-447 (2008)
139. LA Szczech: Hypertension and medication-related renal dysfunction in the HIV-infected patient. Semin Nephrol 21, 386-393 (2001) (Pubitemid 32643167)
140. HM Crane, C Grunfeld, RD Harrington, MM Kitahata: Lipoatrophy and lipohypertrophy are independently associated with hypertension. HIV Med 10, 496-503 (2009)
141. G Schillaci, GV De Socio, G Pucci, MR Mannarino, J Helou, M Pirro, E Mannarino: Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension 52, 308-313 (2008)
142. G Barbaro: Vascular injury, hypertension and coronary artery disease in human immunodeficiency virus infection. Clin Ter 159, 51-55 (2008) (Pubitemid 351363584)
143. AC May: Percent sequence identity; the need to be explicit. Structure 12, 737-738 (2004) (Pubitemid 38595762)
144. D Kanduc: Immunogenicity in peptideimmunotherapy: from self/nonself to similar/dissimilar sequences. Adv Exp Med Biol 640, 198-207 (2008)
145. K Landsteiner, J Van der Scheer: On the serological specificity of peptides. III. J Exp Med 69, 705-719 (1939)
146. MJ Reddehase, JB Rothbard, UH Koszinowski: A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337, 651-653 (1989) (Pubitemid 19054293)
147. T Yamamura, JT Konola, H Wekerle, MB Lees: Monoclonal antibodies against myelin proteolipid protein: identification and characterization of two major determinants. J Neurochem 57, 1671-1680 (1991) (Pubitemid 21922805)
148. CW Stephen, DP Lane: Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library. J Mol Biol 225, 577-583 (1992)
149. U Fiebig, M Schmolke, M Eschricht, R Kurth, J Denner: Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope. AIDS 23, 887-895 (2009)
150. R Tiwari, J Geliebter, A Lucchese, A Mittelman, D Kanduc: Computational peptide dissection of Melana/MART-1 oncoprotein antigenicity. Peptides 25, 1865-1871 (2004) (Pubitemid 39389180)
151. A Stufano, D Kanduc: Proteome-based epitopic peptide scanning along PSA. Exp Mol Pathol 86, 36-40 (2009)
152. G Lucchese, A Stufano, D Kanduc: Proposing lowsimilarity peptide vaccines against Mycobacterium tuberculosis. J Biomed Biotechnol 832341 (2010)
153. D Kanduc: Protein information content resides in rare peptide segments. Peptides 31, 983-988 (2010)
154. G Lucchese, A Stufano, B Trost, A Kusalik, D Kanduc: Peptidology: short amino acid modules in cell biology and immunology. Amino Acids 33, 703-707 (2007) (Pubitemid 350165425)
155. C Martínez A, MA Marcos, A De La Hera, C Marquez, JM Alonso, ML Toribio, A Coutinho: Immunological consequences of HIV infection: advantage of being low responder casts doubts on vaccine development. Lancet 331, 454-457 (1988) (Pubitemid 18067685)
156. AE Sousa, J Carneiro, M Meier-Schellersheim, Z Grossman, RM Victorino: CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 169, 3400-3406 (2002) (Pubitemid 35013190)
157. G Zandman-Goddard, Y Shoenfeld: HIV and autoimmunity. Autoimmun Rev 1, 329-337 (2002) (Pubitemid 38340245)
158. G Lucchese, A Stufano, D Kanduc: Proteome-guided search for influenza A B-cell epitopes. FEMS Immunol Med Microbiol 57, 88-92 (2009)
159. D Kanduc, L Tessitore, G Lucchese, A Kusalik, E Farber, FM Marincola: Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response. Cancer Immunol Immunother 57, 1215-1223 (2008)
160. B Trost, A Kusalik, G Lucchese, D Kanduc: Bacterial peptides are intensively present throughout the human proteome. Self/Nonself 1(1), 71-74 (2010)
161. B Trost, G Lucchese, A Stufano, M Bickis, A Kusalik, D Kanduc: No human protein is exempt from bacterial motifs. Not even one. Self/Nonself 1(4), 1-7 (2010)
162. D Kanduc: The self-nonself issue: a confrontation between proteomes. Self/Nonself 1(3), 255-258 (2010)
163. D Kanduc: Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes. Biologics 4, 245-261 (2010)
164. MB Oldstone: How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. Virology 234, 179-185 (1997) (Pubitemid 27360108)
165. R Kiessling, G Pawelec, RM Welsh, JD Barry, S Ferrone: Have tumor cells learnt from microorganisms how to fool the immune system? Escape from immune surveillance of tumors and microorganisms: emerging mechanisms and shared strategies. Mol Med Today 6, 344-346 (2000)
166. W Kamp, MB Berk, CJ Visser, HS Nottet: Mechanisms of HIV-1 to escape from the host immune surveillance. Eur J Clin Invest 30, 740-746 (2000) (Pubitemid 30604076)
167. RL Coffman, A Sher, RA Seder: Vaccine adjuvants: putting innate immunity to work. Immunity 33, 492-503 2010
168. WS Pray: Nonprescription product therapeutics Lippincott Williams Wilkins, Philadelphia, Chapter 12, Hemorrhoids, 191-202 (2006)
169. T Yokochi, M Fukada, M Kawai, YH Zhang, GZ Jiang, K Takahashi: Novel adjuvant action of lipopolysaccharides that possess mannose homopolysaccharides as O-specific polysaccharides on immune responses to nonimmunogenic autoantigens in mice. Infect Immun 60, 4953-4956 (1992)
170. A Blanchard, L Montagnier, ML Gougeon: Influence of microbial infections on the progression of HIV disease. Trends Microbiol 5, 326-331 (1997) (Pubitemid 27362296)
171. O Equils, E Faure, L Thomas, Y Bulut, S Trushin, M Arditi: Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. J Immunol 166, 2342-2347 (2001) (Pubitemid 32173467)
172. AA Chaves, RS Baliga, MJ Mihm, BL Schanbacher, A Basuray, C Liu, AC Cook, LW Ayers, JA Bauer: Bacterial lipopolysaccharide enhances cardiac dysfunction but not retroviral replication in murine AIDS: roles of macrophage infiltration and toll-like receptor 4 expression. Am J Pathol 168, 727-735 (2006)
173. K Goodkin, FL Wilkie, M Concha, CH Hinkin, S Symes, TT Baldewicz, D Asthana, RK Fujimura, D Lee, MH Van Zuilen, I Khamis, P Shapshak, C Eisdorfer: Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. J Clin Epidemiol 54, S35-S43 (2001) (Pubitemid 34019142)
174. D Chattopadhya, UK Baveja, M Bose, A Kumar: Disease progression markers during asymptomatic phase of HIV-1 infected children with unimpaired CD4+ cell values: evaluation of repeat CD4+ cell evaluation vs. other immunological parameters. J Trop Pediatr 48, 340-347 (2002) (Pubitemid 36032668)
175. M Dean, M Carrington, C Winkler, GA Huttley, MW Smith, R Allikmets, JJ Goedert, SP Buchbinder, E Vittinghoff, E Gomperts, S Donfield, D Vlahov, R Kaslow, A Saah, C Rinaldo, R Detels, SJ O'Brien: Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856-1862 (1996)
176. M Moriuchi, H Moriuchi, W Turner, AS Fauci: Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. J Clin Invest 102, 1540-1550 (1998) (Pubitemid 28492221)
177. D Goletti, D Weissman, RW Jackson, NM Graham, D Vlahov, RS Klein, Munsiff SS, Ortona L, Cauda R, AS Fauci: Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol 157, 1271-1278 (1996) (Pubitemid 126449644)
178. D Kanduc: "Self-nonself" peptides in the design of vaccines. Curr Pharm Des 15, 3283-9 (2009)
179. D Kanduc: Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects. Expert Opin Biol Ther 9, 45-53 (2009)
180. D Kanduc, R Serpico, A Lucchese, Y Shoenfeld: Correlating low-similarity peptide sequences and HIV B-cell epitopes. Autoimmun Rev 7, 291-296 (2008) (Pubitemid 351284547)
181. A Lucchese, R Serpico, V Crincoli, Y Shoenfeld, D Kanduc: Sequence uniqueness as a molecular signature of HIV-1-derived B-cell epitopes. Int J Immunopathol Pharmacol 22, 639-646 (2009)